Dr. Shivakumar Indi

Yellow skin appearing in a newborn on the second or third day of life is almost always physiological jaundice  -  the normal process by which a newborn's body breaks down the extra red blood cells it no longer needs after birth, releasing bilirubin that the liver is still learning to process efficiently. This is expected and normal, and most term babies develop some visible yellowing between day 2 and day 5 that then fades by day 10 to 14. The yellow appearance alone is not the concern  -  what matters is how high the bilirubin level is, how quickly it is rising, and how old the baby is in hours at any given level. In Vijayapura's hot climate, there is an additional consideration: dehydration in the first days, particularly in exclusively breastfed babies whose milk is not yet fully established, can accelerate bilirubin rise. Feeding frequently  -  at least 8 to 10 times in 24 hours  -  is one of the most important things parents can do in the first days, both to support milk supply and to drive bilirubin clearance through bowel movements. Visit a paediatrician promptly if: the yellow colour appears within the first 24 hours of birth (always abnormal), is spreading to the palms and soles, the baby is very sleepy and difficult to wake for feeds, or the yellow colour is still present and deepening after two weeks. Early review when jaundice appears changes outcomes, particularly in Vijayapura's heat where dehydration risk is real.

Children with asthma have specific additional vaccination needs beyond the standard government schedule, and as a paediatrician with the IAP PAAC credential, I discuss these at every relevant vaccination visit. The two vaccines most specifically relevant for asthmatic children are influenza vaccine and pneumococcal vaccine. Influenza  -  the flu  -  is a powerful asthma trigger. A child with asthma who contracts influenza is significantly more likely to have a severe acute asthma attack requiring emergency care than a child without asthma. Annual influenza vaccination, given each year before the influenza season, substantially reduces the risk of influenza-triggered asthma exacerbations. The IAP recommends annual influenza vaccination for all children with chronic respiratory conditions including asthma, and in Vijayapura, where respiratory infections circulate through school-age children regularly, this recommendation is directly relevant. Pneumococcal vaccine  -  PCV  -  protects against Streptococcus pneumoniae, which causes pneumonia, bacterial meningitis, and ear infections. Pneumonia is a particularly serious event in a child with asthma because it produces severe lower respiratory inflammation that can take weeks to resolve and may produce a prolonged deterioration in asthma control. PCV is on the IAP-recommended schedule for all children, but its relevance for asthmatic children is especially high. I also discuss varicella vaccine for unvaccinated children with asthma, since chickenpox can trigger severe asthma flares and the vaccine eliminates this risk.

IAP PAAC stands for Paediatric Asthma and Allergy Care, a specialist qualification from the Indian Academy of Pediatrics  -  the national professional body for paediatricians in India. The PAAC qualification provides structured training in the evaluation and management of childhood asthma, allergic rhinitis, food allergy, eczema, and other paediatric allergic conditions at a standard endorsed and recognised by the IAP. What it adds to general paediatric training is a specific clinical framework for allergy evaluation  -  the systematic approach to identifying which allergens are driving a child's symptoms, the evidence-based treatment pathways for each allergic condition, and the ability to develop a management plan that addresses the underlying disease rather than only treating each symptomatic episode. In practical terms, when a child with recurrent cough and wheeze comes to my clinic, the PAAC training guides my evaluation from the history  -  the pattern of symptoms, triggers, family allergy history, response to bronchodilators  -  through to the treatment decision. A child correctly identified as having allergic asthma rather than recurrent chest infection receives treatment that actually changes their disease course, rather than another antibiotic course. The IAP PAAC credential represents a commitment to the highest national standard of paediatric allergy and asthma care.

Vijayapura presents a specific combination of environmental factors that makes asthma management in children here more challenging than in many other parts of Karnataka. The semi-arid climate  -  with hot dry summers, red laterite soil that produces fine dust when disturbed, and seasonal agricultural activity  -  means that airborne particulate exposure is substantial and year-round. The district's extensive cultivation of jowar, wheat, sunflower, and sugarcane introduces agricultural pollens during harvest and flowering seasons that can sensitise children and trigger respiratory symptoms. These are not allergens that feature prominently in the allergen profiles studied in major Indian cities, which means that the local clinical experience of treating children in Vijayapura is what makes a paediatrician here particularly well-positioned to identify and manage these regional exposures. Cockroach allergen exposure in Vijayapura's older urban housing is a perennial indoor trigger whose significance is well-established in the allergy literature and which I see frequently driving poorly controlled asthma in children whose families have never been told about cockroach sensitisation. House dust mite is also present in Vijayapura, though at lower levels than in humid coastal cities. For any child with asthma or recurrent wheeze in Vijayapura, understanding the local trigger pattern is the foundation of effective management